Please assess the completion status of the following clinical trial:

Trial Title: Acute Cholecystitis - Early Laparoscopic Surgery Versus Antibiotic Therapy and Delayed Elective Cholecystectomy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients of age \> 18 years~* Patients with acute cholecystitis based on three of the following signs~  * abdominal pain in the upper right quadrant~ * Murphy's sign~ * leucocytosis \> 10 /ml~ * rectal temperature \> 38 °C or \< 36.5 °C plus~ * cholecystolithiasis (stones / sludge) or sonographic signs of cholecystitis (thickening and triple layer formation of the gall bladder wall)~* Immediate antibiotic therapy (400 mg Moxifloxacin i.v. once a day)~* Laparoscopic cholecystectomy possible within 24 hours after presentation of the patient~* Informed consent~Exclusion Criteria:~* ASA IV and V (table 2)~* Septic shock~* Perforation or abscess of the gall bladder~* Impossibility of laparoscopic surgery (further surgery, surgeon, ...)~* Additional need of antibiotics due to secondary disease~* Known intolerability of Moxifloxacin~* Known or possible pregnancy, breast feeding~* Life-threatening diseases (life-expectancy \< 48 hours)~* End-stage liver disease (Child-Pugh C)~* Psychiatric or severe neurologic disease~* Relevant bradycardia or other symptomatic arrhythmias~* Significant cardiac disease~* Known long QT-disorders~* Electrolyte disorders, especially hypocalcemia~* Known intolerability of chinolones~* Earlier participation in this trial

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).